What are the characteristics and relevant considerations for the development and validation of a stability-indicating method?
Joseph Henry
Advertisement
Articles by Joseph Henry
In the pharmaceutical industry, the demonstration of drug substance (DS) or drug product (DP) stability over the shelf life is an important aspect of the regulatory requirements.
Advertisement
Latest Updated Articles
Current Practices and Considerations for a Stability-Indicating Method in Pharmaceutical AnalysisPublished: March 1st 2014 | Updated:
Current Practices and Considerations for a Stability-Indicating Method in Pharmaceutical AnalysisPublished: August 1st 2014 | Updated:
Advertisement
Advertisement
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Advancing RNA-Based Therapeutics: IQ Consortium Experts on Optimizing Chromatographic Bioanalysis
5
